Genomic Valley Biotech Market Cap ($1.60M USD)
Market Cap
₹14.40 Cr
$1.60M USD
As of November 2026
Genomic Valley Biotech Market Cap ($1.60M USD). As of Nov. 19, 2026, Genomic Valley Biotech (GVBL) market capitalisation is ₹14.40 Cr ($1.60M), with 30.68 L shares outstanding at a current price of ₹46.93 on BSE, ranking 4666 out of 5368 companies by market cap in our screener. Genomic Valley Biotech operates in the Healthcare sector and is classified as a Small Cap stock. For live price, earnings and the complete company profile, see GVBL stock price BSE.
Current Price
₹46.93
Outstanding Shares
30.68 L
Market Cap Rank
#4666
Top Percentile
13.1%
Market Cap History of Genomic Valley Biotech (Last 10 Years)
GVBL market capitalisation from year-end BSE closing prices over the last 10 years. Review GVBL earnings multiple to evaluate earnings-based valuation against sector peers.
End of Year Market Cap History — Genomic Valley Biotech
GVBL year-end market cap in INR and USD with closing share price and annual change — BSE closing prices.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹14.40 Cr
$1.60M USD
|
₹46.93 | BSE | +89.92% |
| 2025 |
₹7.58 Cr
$842,446 USD
|
₹24.71 | BSE | -69.09% |
| 2024 |
₹24.53 Cr
$2.73M USD
|
₹79.95 | BSE | +113.54% |
| 2023 |
₹11.49 Cr
$1.28M USD
|
₹37.44 | BSE | +55.68% |
| 2022 |
₹7.38 Cr
$819,945 USD
|
₹24.05 | BSE | +6.89% |
| 2021 |
₹6.90 Cr
$767,100 USD
|
₹22.50 | BSE | - |
| 2020 |
₹6.90 Cr
$767,100 USD
|
₹22.50 | BSE | - |
Market Cap Data Sources
Tickjournal (INR)
₹14.40 Cr
Tickjournal (USD)
$1.60M
Price Source
BSE
USD to INR Rate
₹90.00